Novel substrates

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 5, 2007, Pages 365-370

  Wahed, Mahmood ^a   Geoghegan, Michael ^a   Powell Tuck, Jeremy ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Arginine; Glutamine; Nutritional support; Parenteral nutrition; Taurine; Vitamins

Indexed keywords

ANTIOXIDANT; ARGININE; CITRULLINE; FAT; FATTY ACID; FISH OIL; GAMMA LINOLENIC ACID; GLUTAMINE; ICOSANOID; ICOSAPENTAENOIC ACID; LIPID EMULSION; LONG CHAIN TRIACYLGLYCEROL; MINERAL; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; PREDNISOLONE; TAURINE; VITAMIN;

AMINO ACID BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTIFICIAL FEEDING; BURN PATIENT; CANCER; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; CROHN DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE SEVERITY; ENTERIC FEEDING; GRAM NEGATIVE INFECTION; HUMAN; INFECTION COMPLICATION; INTESTINE MUCOSA; LENGTH OF STAY; LIPID DIET; LIVER FUNCTION TEST; LOW CARBOHYDRATE DIET; LYMPHOCYTE PROLIFERATION; METABOLIC STRESS; NUTRITIONAL REQUIREMENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESPIRATORY QUOTIENT; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TOTAL PARENTERAL NUTRITION; ULCERATIVE COLITIS; WEIGHT REDUCTION;

AMINO ACIDS; ENTERAL NUTRITION; HUMANS; MICRONUTRIENTS; MINERALS; OLIGOSACCHARIDES; PARENTERAL NUTRITION; VITAMINS;

EID: 34247092774     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3280bdc1fc     Document Type: Review

References (68)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-891.
2. Heyland D, Dhaliwal R. Immunonutrition in the critically ill: from old approaches to new paradigms. Intensive Care Med 2005; 31:501-503.
3. Newsholme P, Procopio J, Lima MM, Pithon-Curi TC, Curi R. Glutamine and glutamate - heir central role in cell metabolism and function. Cell Biochem Funct 2003; 21:1-9.
4. Van der Hulst RR, Van Kreel BK, von Meyenfeldt MF, Brummer RJ, Arends JW, Deutz NE, et al. Glutamine and the preservation of gut integrity. Lancet 1993; 341:1363-1365.
5. Burke DJ, Alverdy JC, Aoys E, Moss GS. Glutamine-supplemented total parenteral nutrition improves gut immune function. Arch Surg 1989; 124:1396-1399.
6. Powell-Tuck J, Jamieson CP, Bettany GE, Obeid O, Fawcett HV, Archer C, et al. A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition. Gut 1999; 45:82-88.
7. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997; 13:295-302.
8. Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002; 30:2032-2037.
9. Jian ZM, Cao JD, Zhu XG, Zhao WX, Yu JC, Ma EL, et al. The impact of alanyl-glutamine on clinical safety, nitrogen balance, intestinal permeability, and clinical outcome in postoperative patients: a randomized, double-blind, controlled study of 120 patients. JPEN J Parenter Enteral Nutr 1999; 23 (5 Suppl):S62-S66.
10. Morlion BJ, Stehle P, Wachtler P, Siedhoff HP, Koller M, Konig W, et al. Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg 1998; 227: 302-308.
11. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 1993; 17:407-413.
12. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992; 116:821-828.
13. Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352:772-776.
14. Wischmeyer PE, Lynch J, Liedel J, Wolfson R, Riehm J, Gottlieb L, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 2001; 29:2075-2080.
15. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30:2022-2029.
16. Garrel D, Patenaude J, Nedelec B, Samson L, Dorais J, Champoux J, et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med 2003; 31: 2444-2449.
17. Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R. A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med 2003; 29:1710-1716.
18. Schloerb PR. Immune-enhancing diets: products, components, and their rationales. JPEN J Parenter Enteral Nutr 2001; 25 (2 Suppl):S3-S7.
19. Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003; 6:223-228.
20. Geggel HS, Ament ME, Heckenlively JR, Martin DA, Kopple JD. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl J Med 1985; 312:142-146.
21. Stapleton PP, Charles RP, Redmond HP, Bouchier-Hayes DJ. Taurine and human nutrition. Clin Nutr 1997; 16:103-108.
22. Belli DC. Taurine and TPN solutions? Nutrition 1994; 10:82-84.
23. Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999; 27:1807-1813.
24. Berger MM, Spertini F, Shenkin A, Wardle C, Wiesner L, Schindler C, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr 1998; 68:365-371.
25. Porter JM, Ivatury RR, Azimuddin K, Swami R. Antioxidant therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: early results of a prospective randomized study. Am Surg 1999; 65:478-483.
26. Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005; 31:327-337.
27. Grimble RF. Immunonutrition. Curr Opin Gastroenterol 2005; 21:216-222.
28. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002; 61:345-358.
29. Skipworth JE, Fearon CH. The scientific rationale for optimizing nutritional support in cancer. Eur J Gastroenterol Hepatol 2007; 19:371-377.
30. Grimble RF. Nutritional therapy for cancer cachexia. Gut 2003; 52:1391-1392.
31. Barber MD, Fearon KC, Tisdale MJ, McMillan DC, Ross JA. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 2001; 40:118-124.
32. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 2000; 36:177-184.
33. Tisdale MJ. Biochemical mechanisms of cellular catabolism. Curr Opin Clin Nutr Metab Care 2002; 5:401-405.
34. Fearon KC, von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003; 52:1479-1486.
35. Al Saady NM, Blackmore CM, Bennett ED. High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med 1989; 15:290-295.
36. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999; 27: 1409-1420.
37. Pacht ER, DeMichele SJ, Nelson JL, Hart J, Wennberg AK, Gadek JE. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 2003; 31:491-500.
38. Calder PC, Zurier RB. Polyunsaturated fatty acids and rheumatoid arthritis. Curr Opin Clin Nutr Metab Care 2001; 4:115-121.
39. Rocha PN, Plumb TJ, Coffman TM. Eicosanoids: lipid mediators of inflammation in transplantation. Springer Semin Immunopathol 2003; 25:215-227.
40. van der Heide JJ, Bilo HJ, Donker JM, Wilmink JM, Tegzess AM. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Engl J Med 1993; 329:769-773.
41. Hernandez D, Guerra R, Milena A, Torres A, Garcia S, Garcia C, et al. Dietary fish oil does not influence acute rejection rate and graft survival after renal transplantation: a randomized placebo-controlled study. Nephrol Dial Transplant 2002; 17:897-904.
42. Takatsuka H, Takemoto Y, Iwata N, Suehiro A, Hamano T, Okamoto T, et al. Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 2001; 28:769-774.
43. Lindgren BF, Ruokonen E, Magnusson-Borg K, Takala J. Nitrogen sparing effect of structured triglycerides containing both medium- and long-chain fatty acids in critically ill patients; a double blind randomized controlled trial. Clin Nutr 2001; 20:43-48.
44. Bellantone R, Bossola M, Carriero C, Malerba M, Nucera P, Ratto C, et al. Structured versus long-chain triglycerides: a safety, tolerance, and efficacy randomized study in colorectal surgical patients. JPEN J Parenter Enteral Nutr 1999; 23:123-127.
45. Rubin M, Moser A, Vaserberg N, Greig F, Levy Y, Spivak H, et al. Structured triacylglycerol emulsion, containing both medium- and long-chain fatty acids, in long-term home parenteral nutrition: a double-blind randomized cross-over study. Nutrition 2000; 16:95-100.
46. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2001;CD000542.
47. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr 1995; 19:356-364.
48. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995; 108:1056-1067.
49. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol 1996; 31:267-272.
50. Fernandez-Banares F, Cabre E, Gonzalez-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn's disease. Gut 1994; 35 (1 Suppl):S55-S59.
51. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 1995; 14:229-236.
52. Gassull MA, Fernandez-Banares F, Cabre E, Papo M, Giaffer MH, Sanchez-Lombrana JL, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002; 51:164-168.
53. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334:1557-1560.
54. Belluzzi A. N-3 fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc 2002; 61:391-395.
55. MacLean CH, Mojica WA, Newberry SJ, Pencharz J, Garland RH, Tu W, et al. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr 2005; 82:611-619.
56. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108:975-982.
57. Den Hond E, Geypens B, Ghoos Y. Effect of high performance chicory inulin on constipation. Nutr Res 2000; 20:731-736.
58. Rao VA. The prebiotic properties of oligofructose at low intake levels. Nutr Res 2001; 21:843-848.
59. Griffin IJ, Davila PM, Abrams SA. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br J Nutr 2002; 87 (Suppl 2):S187-S191.
60. Van den Heuvel EG, Muys T, van Dokkum W, Schaafsma G. Oligofructose stimulates calcium absorption in adolescents. Am J Clin Nutr 1999; 69:544-548.
61. Silk DB, Walters ER, Duncan HD, Green CJ. The effect of a polymeric enteral formula supplemented with a mixture of six fibres on normal human bowel function and colonic motility. Clin Nutr 2001; 20:49-58.
62. Schneider SM, Girard-Pipau F, Anty R, van der Linde EG, Philipsen-Geerling BJ, Knol J, et al. Effects of total enteral nutrition supplemented with a multifibre mix on faecal short-chain fatty acids and microbiota. Clin Nutr 2005.
63. Vandewoude MF, Paridaens KM, Suy RA, Boone MA, Strobbe H. Fibre-supplemented tube feeding in the hospitalised elderly. Age Ageing 2005; 34:120-124.
64. Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000; 342:1392-1398.
65. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999; 69:30-42.
66. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944-953.
67. Kehlet H, Buchler MW, Beart RWJr, Billingham RP, Williamson R. Care after colonic operation: is it evidence-based? Results from a multinational survey in Europe and the United States. J Am Coll Surg 2006; 202:45-54.
68. Buzby GP, Williford WO, Peterson OL, Crosby LO, Page CP, Reinhardt GF, et al. A randomized clinical trial of total parenteral nutrition in malnourished surgical patients: the rationale and impact of previous clinical trials and pilot study on protocol design. Am J Clin Nutr 1988; 47 (2 Suppl):357-365.